Leavell Investment Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$372K Sell
1,908
-300
-14% -$62.2K 0.01% 496
2026
Q1
$496K Buy
2,208
+105
+5% +$26.2K 0.02% 419
2025
Q4
$507K Hold
2,103
0.02% 406
2025
Q3
$576K Hold
2,103
0.02% 384
2025
Q2
$543K Buy
2,103
+3
+0.1% +$716 0.02% 390
2025
Q1
$470K Sell
2,100
-33
-2% -$7.7K 0.02% 394
2024
Q4
$488K Buy
2,133
+33
+2% +$7.95K 0.02% 380
2024
Q3
$513K Hold
2,100
0.03% 374
2024
Q2
$402K Sell
2,100
-600
-22% -$122K 0.02% 392
2024
Q1
$535K Hold
2,700
0.03% 342
2023
Q4
$464K Hold
2,700
0.03% 338
2023
Q3
$399K Hold
2,700
0.03% 357
2023
Q2
$590K Hold
2,700
0.04% 311
2023
Q1
$591K Hold
2,700
0.04% 308
2022
Q4
$562K Hold
2,700
0.04% 305
2022
Q3
$589K Hold
2,700
0.05% 290
2022
Q2
$566K Buy
2,700
+400
+17% +$85.2K 0.04% 294
2022
Q1
$558K Hold
2,300
0.04% 294
2021
Q4
$599K Hold
2,300
0.04% 293
2021
Q3
$606K Sell
2,300
-1,800
-44% -$492K 0.05% 274
2021
Q2
$795K Hold
4,100
0.06% 231
2021
Q1
$795K Hold
4,100
0.06% 231
2020
Q4
$871K Hold
4,100
0.08% 211
2020
Q3
$703K Sell
4,100
-700
-15% -$129K 0.06% 223
2020
Q2
$922K Sell
4,800
-1,000
-17% -$164K 0.09% 181
2020
Q1
$854K Sell
5,800
-2,000
-26% -$319K 0.1% 171
2019
Q4
$1.21M Hold
7,800
0.11% 166
2019
Q3
$1.05M Hold
7,800
0.11% 176
2019
Q2
$952K Hold
7,800
0.1% 187
2019
Q1
$811K Hold
7,800
0.09% 196
2018
Q4
$888K Hold
7,800
0.11% 183
2018
Q3
$900K Hold
7,800
0.1% 194
2018
Q2
$808K Hold
7,800
0.09% 200
2018
Q1
$768K Hold
7,800
0.09% 209
2017
Q4
$661K Hold
7,800
0.08% 225
2017
Q3
$600K Hold
7,800
0.07% 229
2017
Q2
$607K Hold
7,800
0.08% 219
2017
Q1
$561K Hold
7,800
0.07% 227
2016
Q4
$484K Hold
7,800
0.07% 243
2016
Q3
$505K Hold
7,800
0.07% 235
2016
Q2
$493K Hold
7,800
0.07% 239
2016
Q1
$451K Buy
7,800
+342
+5% +$19.4K 0.07% 244
2015
Q4
$400K Buy
7,458
+58
+0.8% +$3.27K 0.06% 255
2015
Q3
$377K Sell
7,400
-500
-6% -$26.9K 0.06% 264
2015
Q2
$445K Buy
7,900
+500
+7% +$31.6K 0.07% 254
2015
Q1
$531K Buy
7,400
+200
+3% +$13K 0.08% 225
2014
Q4
$404K Hold
7,200
0.06% 273
2014
Q3
$355K Hold
7,200
0.06% 280
2014
Q2
$365K Buy
7,200
+500
+7% +$24.8K 0.06% 273
2014
Q1
$299K Hold
6,700
0.05% 313
2013
Q4
$315K Hold
6,700
0.05% 296
2013
Q3
$354K Hold
6,700
0.06% 262
2013
Q2
$302K Buy
+6,700
New +$318K 0.06% 286

Other funds holding RMD

Leavell Investment Management's RMD Position: Q2 2026 in Review

Leavell Investment Management reduced its ResMed (RMD) stake by 14% in Q2 2026, selling an estimated $62.2K and leaving 1,908 shares worth $372K. The position accounts for 0.01% of the portfolio, ranked #496.

Leavell Investment Management first reported a position in RMD in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.21M in Q4 2019. 161 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Leavell Investment Management held 1,908 shares of ResMed worth $372K as of Q2 2026.
  • Leavell Investment Management sold 300 ResMed shares in Q2 2026, an estimated $62.2K.
  • ResMed made up 0.01% of Leavell Investment Management's portfolio in Q2 2026, its #496 holding.
  • Leavell Investment Management first reported a position in ResMed in Q2 2013 and has held it in 53 quarters since.
  • Leavell Investment Management's ResMed position peaked at $1.21M in Q4 2019.
  • 161 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Leavell Investment Management's 13F filing for Q2 2026, filed 21 Jul 2026.